Background. The rollout of the group A meningococcal vaccine, PsA-TT, in Africa's meningitis belt countries represented the first introduction of a vaccine specifically designed for this part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback